Extravascular Cardioverter-Defibrillator for Primary Prevention in an 11-Year-Old Boy With Phenotype of High Risk Overlapping Cardiomyopathies.

Abstract excerpt

BACKGROUND: The extravascular implantable cardioverter-defibrillator (EV-ICD; Aurora™, Medtronic) is a novel non-transvenous system introduced in 2023. While its safety and efficacy have been demonstrated in adults, experience in pediatric patients remains limited despite potential advantages in this population. CASE PRESENTATION: We report an 11-year-old boy with complex cardiomyopathy (hypertrophic, dilated,...

Topics

Join the communities discussing this publication.

• Cardiomyopathies
• Cardiomyopathy, Dilated
• Cardiomyopathy, Hypertrophic
• Death, Sudden, Cardiac
• Defibrillators, Implantable